My Portfolio
+
LINK YOUR PORTFOLIO

Valneva SE VLA-FR:Euronext Paris

*Data is delayed | Exchange | EUR
Last | 06/03/26 CEST
2.38UNCH (UNCH)
52 week range
2.14 - 5.42
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.38
  • 52 Week High5.42
  • 52 Week High Date08/18/25
  • 52 Week Low2.14
  • 52 Week Low Date05/04/26

Latest On Valneva SE

Key Stats

  • Market Cap451.276M
  • Shares Out189.77M
  • 10 Day Average Volume0.70M
  • Dividend-
  • Dividend Yield-
  • Beta1.78

Latest On Valneva SE

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.38
  • 52 Week High5.42
  • 52 Week High Date08/18/25
  • 52 Week Low2.14
  • 52 Week Low Date05/04/26
  • Market Cap451.276M
  • Shares Out189.77M
  • 10 Day Average Volume0.70M
  • Dividend-
  • Dividend Yield-
  • Beta1.78

RATIOS/PROFITABILITY

  • EPS (TTM)-0.80
  • P/E (TTM)-2.95
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-99.364M
  • ROE (TTM)-109.57%
  • Revenue (TTM)156.331M
  • Gross Margin (TTM)29.46%
  • Net Margin (TTM)-88.30%
  • Debt To Equity (MRQ)273.15%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli...
Anne-Marie Graffin
Independent Chairman of the Board
Thomas Lingelbach
President, Chief Executive Officer, Director
Vincent Dequenne
Chief Operating Officer
Peter Buehler
Chief Financial Officer
Kendra Wergin
General Counsel, Corporate Secretary
Address
6, Rue Alain Bombard
Lyon
69002
France